Abstract
A vaginal clear-cell adenocarcinoma developed in a young woman who had been exposed in utero to maternal stilboestrol treatment. During 1940-71 in the UK some 7500 women were given stilboestrol during pregnancy. Thus more cases are likely to appear and clinicians caring for young women should be alert to this possibility.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Poskanzer D. C., Herbst A. L. Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero. Cancer. 1977 Apr;39(4 Suppl):1892–1895. doi: 10.1002/1097-0142(197704)39:4+<1892::aid-cncr2820390823>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]